The GHK-Cu Copper Peptide Serum is formulated with a specific goal: to provide a balanced, effective peptide complex that works with your skins natural processes
Created by a functional dietitian with dual expertise in bariatric nutrition and counseling, this guide reflects real-world clinical experience with thousands of weight management clients
Harder S, Fuhr U, Staib AH, Wolff T
Methods Study design The SEMPA trial (Effect of Empagliflozin and Semaglutide on Cardio-Renal Target Organ Damage in Patients with Type 2 Diabetes A Randomized Trial) was a 32 week investigator-initiated, randomised, partly placebo-controlled, partly open-label trial, designed to assess the separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and arterial stiffness as two co-primary outcomes
Recent Developments: In June 2025, Eli Lilly and Company entered a high-value partnership with Camurus to develop long-acting GLP-1 and dual/triple incretin therapies using Camurus proprietary FluidCrystal technology, with deal terms that could reach up to $870 million
Highly recommend the HydraFacial